MB
MPM BioImpact’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Buy |
1,720,741
+615,297
| +56% | +$8.07M | 3.91% | 6 |
|
|
2025
Q1 | $24.3M | Buy |
1,105,444
+26,128
| +2% | +$575K | 4.18% | 4 |
|
|
2024
Q4 | $28.8M | Buy |
1,079,316
+162,150
| +18% | +$4.33M | 4.09% | 3 |
|
|
2024
Q3 | $24.5M | Buy |
917,166
+176,505
| +24% | +$4.71M | 3.67% | 6 |
|
|
2024
Q2 | $13.3M | Buy |
740,661
+299,402
| +68% | +$5.39M | 2.07% | 15 |
|
|
2024
Q1 | $8.05M | Buy |
+441,259
| New | +$8.05M | 1.29% | 32 |
|
|
2023
Q3 | – | Sell |
-712,798
| Closed | -$5.52M | – | 33 |
|
|
2023
Q2 | $5.52M | Buy |
+712,798
| New | +$5.52M | 1.11% | 27 |
|
|
2022
Q4 | – | Sell |
-304,027
| Closed | -$2.99M | – | 39 |
|
|
2022
Q3 | $2.99M | Buy |
+304,027
| New | +$2.99M | 0.71% | 26 |
|